Treatment Costs
Zimmer extends robotic surgery distribution deal
Oct 20, 2026
Cancer Costs, Exposed

Johnson & Johnson’s medtech revenue growth stalls at 2.5% in Q3, missing projections amid Abiomed’s underperformance after a $16.6B acquisition.










Johnson & Johnson’s medtech revenue growth stalls at 2.5% in Q3, missing projections amid Abiomed’s underperformance after a $16.6B acquisition.





Zenflow secures $52 million in funding for its urology device to treat benign prostatic hyperplasia.
Stryker CEO Kevin Lobo steps down after 15 years, with COO Spencer Stiles taking over...
Surrogacy may put a marriage to the test, about one of life's biggest challenges, with...



